Cantel Announces Initiatives to Help Fight COVID-19

April 1, 2020

Company takes specific actions around mask and PPE production, product innovation and education.

Press Release (pdf)

LITTLE FALLS, N.J., April 1, 2020 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) announced today specific areas of focus and associated actions to combat the COVID-19 virus. In these unprecedented times, the company is concentrating on enhanced production, product innovation and value-add COVID-19 education in support of first-responders and other healthcare professionals.

"We are doing everything we can to contribute to the global effort focused on addressing the COVID-19 pandemic," said George Fotiades, President and Chief Executive Officer of Cantel. "Supporting those on the front lines, in addition to our global employee base, is job one, and we are working closely with distribution partners to ensure that our masks, PPE and other infection prevention solutions are going to those who are most in need. Infection prevention is the core of our company's mission, and we are doing everything possible to deliver key products and services to serve and protect healthcare professionals." Cantel is working across divisions to bring critical products it manufactures and sells to various end markets to best serve healthcare providers on the front lines.

Cantel has focused on accelerating surgical earloop mask production by its HuFriedyGroup dental division, increasing manufacturing to 24 hours a day, seven days a week at the organization's two New York manufacturing sites and expanding manufacturing lines to increase production volume by over 50%. The enhanced hours and expanded production capacity have enabled the production of over 4.4 million masks per week to serve healthcare professionals. Recently, the organization has increased its manufacturing output on protective face shields by 50% and anticipates an increase of output by 100% in two weeks. These products are being deployed to medical and dental customers. 

In addition to masks, HuFriedyGroup is focused on increasing sourcing through sub-suppliers to increase product availability on key products lines such as hand sanitizer, hand sanitizing wipes, protective eye wear, and surface disinfectants. These products span a variety of HuFriedyGroup brands including Crosstex, Hu-Friedy, and Palmero.

Cantel is also focused on innovating products that play a major role on the front lines of combatting COVID-19. On the dental    side, AdvantaClear™surface disinfectant is designed to clean and disinfect surfaces while effectively killing a broad spectrum of disease-causing microorganisms in one minute. Importantly, AdvantaClear surface disinfectant has been added to the EPA List N: Disinfectants for Use Against SARS-CoV-2, and is classified as being effective against SARS-CoV-2, the cause of COVID-19.

Cantel's ACTRIL™ Cold Sterilant surface disinfectant, traditionally sold into the life sciences segment, is another example of unique product innovation. ACTRIL Cold Sterilant is a powerful disinfectant containing a proprietary mixture of 0.08% peracetic  acid and 1.0% hydrogen peroxide. It is effective against a broad spectrum of organisms, including bacterial spores, fungal spores, bacteria, mycobacteria, yeast, molds, and viruses. Cantel is actively working with its medical division to offer this powerful disinfectant to hospital customers to help in the fight against infections.

Cantel has made significant investments in the area of COVID-19 education. The COVID-19 Resource Center as well as a  series of infection prevention webinars and podcasts, developed by the dental division, have been visited and attended by close to 20,000 people. The GreenLight Dental Compliance Center, a first-of-its-kind solution, provides a single, convenient online portal that contains everything a dental practice needs to develop and maintain a compliant infection prevention program. Cantel remains focused on providing its customers a "Complete Circle of Protection" that includes workflow management solutions, instrument reprocessing, infection prevention, and compliance. The initial deployment of these programs is to the dental  community through the HuFriedyGroup business. In the weeks and months ahead, Cantel will look to expand these key  educational resources to the Medivators business serving its medical customers.

For media inquiries, contact Patrick Bernardi, HuFriedyGroup Chief Marketing Officer, at pbernardi@hu-friedy.com or 773.868.5806.

About Cantel Medical:

Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, instruments and instrument reprocessing workflow systems serving the dental industry, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com.

About HuFriedyGroup:

HuFriedyGroup, a wholly owned subsidiary of Cantel Medical Corp. (NYSE: CMD), is the global leader in infection prevention, instrument manufacturing, and instrument reprocessing workflows, with over 177 years of collective experience in the dental industry. HuFriedyGroup helps dental professionals be the best in practice by providing a complete circle of protection in the dental suite, bringing world class products, services, education, and communities that result in superior clinician performance, superior clinical outcomes, and safety for clinicians and patients. Headquartered in Chicago, HuFriedyGroup products are distributed in more than 100 countries, and the company maintains offices in Germany, Italy, China, Singapore, and Japan. For further information, visit www.hu-friedy.com.

About Mar Cor Purification:

Mar Cor Purification, Inc., a wholly owned subsidiary of Cantel Medical Corp. (NYSE: CMD), is a water purification company and is the largest supplier of dialysis medical water systems in North America. It has facilities in 30 cities in the United States and Canada, including nine ion exchange resin regeneration plants strategically located in large metropolitan areas. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria-controlled applications. Unique hollow fiber filtration/separation products and Peracetic acid (PAA) disinfectants are provided through a worldwide distribution network. For further information, visit www.mcpur.com.

About Medivators:

Medivators Inc., a wholly owned subsidiary of Cantel Medical Corp. (NYSE: CMD), is a leader in the design, development and manufacture of medical devices critical to endoscopy and infection prevention. The company offers a comprehensive line of endoscope reprocessing products including market-leading detergents, disinfectants and sterilants; technologically advanced automated endoscope reprocessors; single-use valves and other endoscopy procedure products; drying and storage cabinets; and equipment tracking systems. Our product and service offerings come together in our Complete Circle of Protection, an infection prevention program designed to help customers streamline reprocessing workflow, improve department efficiency, and reduce the risk of infection. For more information visit www.medivators.com.

View original content to download multimedia: https://www.prnewswire.com/news-releases/cantel-announces-initiatives-to-help-fight-covid-19-301033435.html

SOURCE Cantel Medical Corp.

###